T255. WHO PARTICIPATED IN FAMILY WORK IN THE US RAISE-ETP FIRST EPISODE SAMPLE?

por Glynn, Shirley, Gingerich, Susan, Meyer-Kalos, Piper, Mueser, Kim, Chan-Golston, Alec, Sugar, Catherine, Schooler, Nina, Kane, John
Publicado 2018

T39. NEURAL MECHANISMS OF METABOTROPIC GLUTAMATE RECEPTOR 3 MEDIATED ENHANCEMENT OF SYNAPTIC PLASTICITY AND COGNITION

por Stansley, Branden, Joffe, Max, Yohn, Samantha, Lindsley, Craig, Niswender, Colleen, Jeffrey Conn, P
Publicado 2018

F222. CONCRETE THINKING PATTERN IN DAILY DECISION-MAKING PROCESS OF PATIENTS WITH SCHIZOPHRENIA: THROUGH EYE-TRACKING

por Kim, Soo-Jeong, Hong, Yeon-Ju, Kim, Min-Woo, Jung, Young-Hoon, Kim, Jae-Jin
Publicado 2018

40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA

por Purves-Tyson, Tertia, Rothmond, Debora, Weickert, Cynthia Shannon
Publicado 2018

S239. PREDICTIVE ACCURACY FOR WORK OUTCOME IN PATIENTS WITH SCHIZOPHRENIA

por Sumiyoshi, Chika, Fujino, Haruo, Sumiyoshi, Tomiki, Yamamori, Hidenaga, Kudo, Noriko, Azechi, Hirotsugu, Fujimoto, Michiko, Yasuda, Yuka, Ohi, Kazutaka, Hashimoto, Ryota
Publicado 2018

T254. IMPACT OF A DROP IN, OPEN ENDED, PSYCHO EDUCATIONAL GROUP ON CLIENT ENGAGEMENT IN AN EARLY PSYCHOSIS INTERVENTION PROGRAM

por Morris, Crystal, Sadeh, Elham, McMillan, Greg, Robertson, Sharman
Publicado 2018

40.4 LOW-DOSE RISPERIDONE TREATMENT IN ADOLESCENCE PREVENTS THE DEVELOPMENT OF NEUROINFLAMMATION IN THE MATERNAL IMMUNE ACTIVATION MODEL

por Weiner, Ina, Pery, Shani, Dhawan, Jasbeer, Biegon, Anat, Piontkewitz, Yael
Publicado 2018

T153. CAN COGNITIVE TRAINING DECREASE REACTIVE AGGRESSION IN SCHIZOPHRENIA?

por Ahmed, Anthony, Hoptman, Matthew, Lindenmayer, Jean-Pierre
Publicado 2018

31.1 OPTIMISING THE TREATMENT AND MANAGEMENT OF FIRST-EPISODE SCHIZOPHRENIA: THE OPTIMISE CLINICAL TRIAL

por Kahn, René
Publicado 2018

T253. THE CORRELATION ANALYSIS BETWEEN RENAMING SCHIZOPHRENIA AND VISITING FREQUENCY OF MENTAL HEALTH SERVICES BY BIG DATA ANALYSIS (INTERNET SEARCHES AND NEWSPAPER ARTICLES) IN SO...

por Lee, Sang Yup, Hong, Kyung Sue, Joo, Yeon Ho, Koike, Shinsuke, Lee, Yu Sang, Kwon, Jun Soo
Publicado 2018

F237. DOPAMINERGIC EFFECTS ON HIERARCHICAL PREDICTION ERRORS AND CONNECTIVITY DURING SOCIAL LEARNING

por Hauke, Daniel, Diaconescu, Andreea, Wellstein, Katharina, Tomiello, Sara, Rigoux, Lionel, Heinzle, Jakob, Stephan, Klaas Enno
Publicado 2018

T196. CALRETININ INTERNEURON DENSITY IN THE CAUDATE NUCLEUS IS LOWER IN SCHIZOPHRENIA

por Adorjan, Istvan, Sun, Bin, Feher, Virginia, Tyler, Teadora, Damo-Csorba, Bori, Pour, Benedek, Veres, Daniel, Ansorge, Olaf, Chance, Steven Andrew, Szele, Francis
Publicado 2018

F93. SUBCLINICAL PSYCHOSIS COMPONENTS MAKE DIRECT AND INDIRECT CONTRIBUTIONS TO ACTIVE SUICIDE IDEATION IN ADOLESCENTS

por Linscott, Richard, Parker, Theresa
Publicado 2018

O4.7. PLACENTAL GENE EXPRESSION, OBSTETRICAL HISTORY AND POLYGENIC RISK FOR SCHIZOPHRENIA

por Ursini, Gianluca, Punzi, Giovanna, Chen, Qiang, Marenco, Stefano, Robinson, Joshua F, Porcelli, Annamaria, Hamilton, Emily, Mitjans, Marina, Maddalena, Giancarlo, Begemann, Martin, Seidel, Jan, Yanamori, Hidenaga, Jaffe, Andrew E, Berman, Karen F, Egan, Michael F, Straub, Richard, Colantuoni, Carlo, Blasi, Giuseppe, Hashimoto, Ryota, Rujescu, Dan, Ehrenreich, Hannelore, Bertolino, Alessandro, Weinberger, Daniel
Publicado 2018

F54. PHARMACOLOGICAL ENHANCEMENT OF COGNITION AND SOCIAL COGNITION IN THE PSYCHOSIS SPECTRUM

por Mercedes Perez-Rodriguez, M, Rosell, Daniel, Moeller, Scott, Kundu, Prantik, McCLure, Margaret, Hazlett, Erin, New, Antonia
Publicado 2018

O9.5. ABERRANT DOPAMINE SYSTEM FUNCTION REVERSED BY THE OREXIN RECEPTOR ANTAGONIST TCS1102 IN A RODENT MODEL OF SCHIZOPHRENIA

por Perez, Stephanie, Lodge, Daniel
Publicado 2018

S23. INTRODUCING COMPASS: COMPARING BRAIN ACTIVITY ACROSS PATIENTS WITH DIFFERENTIAL TREATMENT RESPONSE IN SCHIZOPHRENIA – AN OBSERVATIONAL STUDY

por Iglesias, Sandra, Siemerkus, Jakob, Bischof, Martin, Tomiello, Sara, Schöbi, Dario, Weber, Lilian, Heinzle, Jakob, Möller, Julian, Egger, Stephan, Gerke, Wolfgang, Baumgartner, Markus, Kawohl, Wolfram, Borgwardt, Stefan, Kaiser, Stefan, Haker, Helene, Stephan, Klaas Enno
Publicado 2018

7.1 ELECTRORETINOGRAPHIC ANOMALIES IN SCHIZOPHRENIA AND THEIR RELATIONSHIPS WITH RETINAL STRUCTURE, VISUAL FUNCTIONS, CLINICAL SYMPTOMS, AND MEDICAL COMORBIDITIES

por Silverstein, Steven, Demmin, Docia, Erickson, Molly, Thompson, Judy, Paterno, Danielle, Netser, Roni
Publicado 2018

T122. UNMET NEEDS IN PATIENTS WITH ACUTE TRANSIENT PSYCHOTIC DISORDERS (ATPD): ANALYSIS OF PATHWAYS TO CARE: AN 8 YEARS FOLLOW-UP STUDY

por Minichino, Amedeo, Rutigliano, Grazia, Merlino, Sergio, Davies, Cathy, Oliver, Dominic, De Micheli, Andrea, McGuire, Philip, Fusar-Poli, Paolo
Publicado 2018

T36. THE ANTIPSYCHOTIC-LIKE PROPERTIES OF EVENAMIDE (NW-3509) REFLECT THE MODULATION OF GLUTAMATERGIC DYSREGULATION

por Bortolato, Marco, Faravelli, Laura, Anand, Ravi
Publicado 2018